Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Pittsburgh, Washington University in St. Louis, University of North Carolina at Chapel Hill, UNM Comprehensive Cancer Center, Virginia Commonwealth University, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Duke Medical Center, University of Chicago
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2764085044